BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8797869)

  • 21. Development of a polyclonal antibody with defined specificity against synthetic peptides from the N-myc oncoprotein using multiple antigen peptide and hemocyanin conjugation methods.
    Yang HW; Ikeda H; Kato K; Nakagawara A; Choi SH; Hayashi Y; Obana K; Hemmi H; Tsuchida Y
    J Pediatr Surg; 1999 Mar; 34(3):454-60. PubMed ID: 10211653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
    Bergqvist M; Brattström D; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Wagenius G; Brodin O
    Anticancer Res; 1998; 18(3B):1999-2002. PubMed ID: 9677456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proteome analysis of autoantibodies in sera of patients with cancer].
    Ueda K
    Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
    Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
    Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma.
    Masutomi K; Kaneko S; Yasukawa M; Arai K; Murakami S; Kobayashi K
    Oncogene; 2002 Aug; 21(38):5946-50. PubMed ID: 12185596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
    Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
    Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M; Efferth T; Mattern J
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of bacterially expressed GST/EBNA-1 fusion proteins for detection of antibodies in sera from patients with nasopharyngeal carcinoma and healthy donors.
    Chen MR; Yang JF; Hsu TY; Liu MY; Chen JY; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 May; 29(2):65-79. PubMed ID: 10592788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
    Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
    Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental induction of immunity by anti-idiotypic vaccines against small-cell-lung cancer].
    Li Y; Hu JY; Zhang Y; Zhu MJ; Zhao XT
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):269-72. PubMed ID: 15996316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.
    Rohayem J; Diestelkoetter P; Weigle B; Oehmichen A; Schmitz M; Mehlhorn J; Conrad K; Rieber EP
    Cancer Res; 2000 Apr; 60(7):1815-7. PubMed ID: 10766164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of enzymatically active human Myc-tagged-NCre recombinase exhibiting immunoreactivity with anti-Myc antibody.
    Watanabe S; Honma D; Furusawa T; Sakurai T; Sato M
    Mol Reprod Dev; 2006 Nov; 73(11):1345-52. PubMed ID: 16894573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
    Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
    Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients.
    Kobayashi S; Hoshino T; Hiwasa T; Satoh M; Rahmutulla B; Tsuchida S; Komukai Y; Tanaka T; Matsubara H; Shimada H; Nomura F; Matsushita K
    Oncotarget; 2016 Dec; 7(50):82493-82503. PubMed ID: 27756887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
    Pape KA; Floyd-Smith G
    Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to c-myc nuclear protein products in autoimmune disease.
    Yamauchi T; Naoe T; Kurosawa Y; Shiku H; Yamada K
    Immunology; 1990 Jan; 69(1):117-20. PubMed ID: 2179128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
    Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.